115 related articles for article (PubMed ID: 14729107)
1. Characterization of human urinary bladder KATP channels containing SUR2B splice variants expressed in L-cells.
Scott VE; Davis-Taber RA; Silvia C; Hoogenboom L; Choi W; Kroeger P; Whiteaker KL; Gopalakrishnan M
Eur J Pharmacol; 2004 Jan; 483(2-3):195-205. PubMed ID: 14729107
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of human SUR2-containing K(ATP) channels.
Davis-Taber R; Choi W; Feng J; Hoogenboom L; McNally T; Kroeger P; Shieh CC; Simmer R; Brioni JD; Sullivan JP; Gopalakrishnan M; Scott VE
Gene; 2000 Oct; 256(1-2):261-70. PubMed ID: 11054556
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells.
Gopalakrishnan M; Whiteaker KL; Molinari EJ; Davis-Taber R; Scott VE; Shieh CC; Buckner SA; Milicic I; Cain JC; Postl S; Sullivan JP; Brioni JD
J Pharmacol Exp Ther; 1999 Apr; 289(1):551-8. PubMed ID: 10087049
[TBL] [Abstract][Full Text] [Related]
4. Putative subunits of the rat mesangial KATP: a type 2B sulfonylurea receptor and an inwardly rectifying K+ channel.
Szamosfalvi B; Cortes P; Alviani R; Asano K; Riser BL; Zasuwa G; Yee J
Kidney Int; 2002 May; 61(5):1739-49. PubMed ID: 11967023
[TBL] [Abstract][Full Text] [Related]
5. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
6. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
[TBL] [Abstract][Full Text] [Related]
7. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
8. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C modulation of recombinant ATP-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B.
Thorneloe KS; Maruyama Y; Malcolm AT; Light PE; Walsh MP; Cole WC
J Physiol; 2002 May; 541(Pt 1):65-80. PubMed ID: 12015420
[TBL] [Abstract][Full Text] [Related]
11. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of a novel class of naphthyl amide KATP channel openers.
Turner SC; Carroll WA; White TK; Brune ME; Buckner SA; Gopalakrishnan M; Fabiyi A; Coghlan MJ; Scott VE; Castle NA; Daza AV; Milicic I; Sullivan JP
Bioorg Med Chem Lett; 2003 May; 13(10):1741-4. PubMed ID: 12729655
[TBL] [Abstract][Full Text] [Related]
13. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
Löffler-Walz C; Hambrock A; Quast U
Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of adenosine receptors and coupling to ATP-sensitive K+ channels in Guinea pig urinary bladder smooth muscle.
Gopalakrishnan SM; Buckner SA; Milicic I; Groebe DR; Whiteaker KL; Burns DJ; Warrior U; Gopalakrishnan M
J Pharmacol Exp Ther; 2002 Mar; 300(3):910-7. PubMed ID: 11861797
[TBL] [Abstract][Full Text] [Related]
15. ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes.
Sim JH; Yang DK; Kim YC; Park SJ; Kang TM; So I; Kim KW
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G137-44. PubMed ID: 11751167
[TBL] [Abstract][Full Text] [Related]
16. K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits.
Yoshida H; Feig JE; Morrissey A; Ghiu IA; Artman M; Coetzee WA
J Mol Cell Cardiol; 2004 Oct; 37(4):857-69. PubMed ID: 15380676
[TBL] [Abstract][Full Text] [Related]
17. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
[TBL] [Abstract][Full Text] [Related]
18. Four novel splice variants of sulfonylurea receptor 1.
Hambrock A; Preisig-Müller R; Russ U; Piehl A; Hanley PJ; Ray J; Daut J; Quast U; Derst C
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C587-98. PubMed ID: 12107069
[TBL] [Abstract][Full Text] [Related]
19. Binding and effect of K ATP channel openers in the absence of Mg2+.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
[TBL] [Abstract][Full Text] [Related]
20. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
